Amgen pays $290M to exit osteoporosis drug deal
Amgen will pay $290 million to end its collaboration with British drugmaker GlaxoSmithKline to commercialize the osteoporosis drug denosumab in certain markets outside the U.S.
A soft touch for transit: CHK America builds interactive route maps for cities
The first unit is being tested at the Santa Barbara MTD Transit Center, where the company will be refining the software that runs the system to make it as useful as possible to riders.
DenMat buys Bay Area firm
In its second acquisition this year, Lompoc-based DenMat has bought G.Hartzell & Son, a dental instruments company in the Bay Area.
Sonos fights Apple spinoffs in patent battle
Wireless speaker maker Sonos made its first-ever disclosure of $535 million in revenue while locked in a patent fight against sophisticated opponents with ties to Apple.
Xirrus targets 2015 for IPO, plans new Wi-Fi products
Thousand Oaks-based Xirrus has rolled out a new line of corporate-grade Wi-Fi devices at a lower price point that it hopes will vastly expand its customer base and set the stage for an initial public offering next year.
